Bojanić Katarina, Pritišanac Ena, Luetić Tomislav, Vuković Jurica, Sprung Juraj, Weingarten Toby N, Carey William A, Schroeder Darrell R, Grizelj Ruža
Division of Neonatology, Department of Obstetrics and Gynecology, University Hospital Merkur, Zagreb, Croatia.
Department of Pediatrics, University of Zagreb, School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
BMC Pediatr. 2015 Oct 12;15:155. doi: 10.1186/s12887-015-0473-x.
Congenital diaphragmatic hernia (CDH) is a congenital malformation associated with life-threatening pulmonary dysfunction and high neonatal mortality. Outcomes are improved with protective ventilation, less severe pulmonary pathology, and the proximity of the treating center to the site of delivery. The major CDH treatment center in Croatia lacks a maternity ward, thus all CDH patients are transferred from local Zagreb hospitals or remote areas (outborns). In 2000 this center adopted protective ventilation for CDH management. In the present study we assess the roles of protective ventilation, transport distance, and severity of pulmonary pathology on survival of neonates with CDH.
The study was divided into Epoch I, (1990-1999, traditional ventilation to achieve normocapnia), and Epoch II, (2000-2014, protective ventilation with permissive hypercapnia). Patients were categorized by transfer distance (local hospital or remote locations) and by acuity of respiratory distress after delivery (early presentation-occurring at birth, or late presentation, ≥ 6 h after delivery). Survival between epochs, types of transfers, and acuity of presentation were assessed. An additional analysis was assessed for the potential association between survival and end-capillary blood CO2 (PcCO2), an indirect measure of pulmonary pathology.
There were 83 neonates, 26 in Epoch I, and 57 in Epoch II. In Epoch I 11 patients (42%) survived, and in Epoch II 38 (67%) (P = 0.039). Survival with early presentation (N = 63) was 48 % and with late presentation 95% (P <0.001). Among early presentation, survival was higher in Epoch II vs. Epoch I (57% vs. 26%, P = 0.031). From multiple logistic regression analysis restricted to neonates with early presentation and adjusting for severity of disease, survival was improved in Epoch II (OR 4.8, 95%CI 1.3-18.0, P = 0.019). Survival was unrelated to distance of transfer but improved with lower partial pressure of PcCO2 on admission (OR 1.16, 95%CI 1.01-1.33 per 5 mmHg decrease, P = 0.031).
The introduction of protective ventilation was associated with improved survival in neonates with early presentation. Survival did not differ between local and remote transfers, but primarily depended on severity of pulmonary pathology as inferred from admission capillary PcCO2.
先天性膈疝(CDH)是一种先天性畸形,与危及生命的肺功能障碍和高新生儿死亡率相关。保护性通气、不太严重的肺部病理改变以及治疗中心与分娩地点的距离可改善预后。克罗地亚主要的CDH治疗中心没有产科病房,因此所有CDH患者均从萨格勒布当地医院或偏远地区(外转患者)转诊而来。2000年该中心采用保护性通气治疗CDH。在本研究中,我们评估保护性通气、转运距离和肺部病理严重程度对CDH新生儿生存的作用。
本研究分为两个阶段,第一阶段(1990 - 1999年,采用传统通气以实现正常碳酸血症)和第二阶段(2000 - 2014年,采用允许性高碳酸血症的保护性通气)。患者按转运距离(当地医院或偏远地区)以及分娩后呼吸窘迫的严重程度(早发 - 出生时出现,或晚发,分娩后≥6小时)进行分类。评估不同阶段、转运类型和发病严重程度之间的生存率。还对生存与终末毛细血管血二氧化碳(PcCO2)之间的潜在关联进行了分析,PcCO2是肺部病理改变的一项间接指标。
共有83例新生儿,第一阶段26例,第二阶段57例。第一阶段11例患者(42%)存活,第二阶段38例(67%)(P = 0.039)。早发患者(n = 63)的生存率为48%,晚发患者为95%(P <0.001)。在早发患者中,第二阶段的生存率高于第一阶段(57%对26%,P = 0.031)。在仅限于早发新生儿并对疾病严重程度进行校正的多因素逻辑回归分析中,第二阶段的生存率有所提高(比值比4.8,95%可信区间1.3 - 18.0,P = 0.019)。生存率与转运距离无关,但入院时较低的PcCO2分压可提高生存率(每降低5 mmHg,比值比1.16,95%可信区间1.01 - 1.33,P = 0.031)。
采用保护性通气与早发新生儿生存率提高相关。当地和偏远地区转运的患者生存率无差异,但主要取决于入院时毛细血管PcCO2所推断的肺部病理严重程度。